Peptides | Notion

Wolverine Protocol (BPC-157/TB-500)

Here’s the real, no-myths version of what’s known (and what isn’t) about BPC-157 and TB-500. This is not advice and I am not a medical professional nor am I recommending to take this, it is purely information.

What they are

BPC-157 (Body Protection Compound-157) is a lab-made 15–amino-acid peptide originally isolated from gastric juice. Preclinical papers claim wide “cytoprotective” effects (gut, tendon/ligament, nerve), but human data are extremely sparse. (PMC)
TB-500 is a shorthand for a peptide based on a fragment/“active site” of thymosin β-4 (TB4), a 43-aa actin-binding protein involved in cell migration and angiogenesis. TB-500 itself has little direct human research; most evidence is on full-length TB4 (different molecule). (Innerbody, PMC)

What the evidence says

BPC-157 (humans): You’ll see many animal studies and enthusiastic reviews. Peer-reviewed reviews acknowledge only limited clinical evidence in humans; one frequently cited line mentions a phase-II signal in ulcerative colitis, but robust, published, controlled human trials for musculoskeletal healing are lacking. A 2025 sports-medicine review notes animal benefits and only very small human data (e.g., one uncontrolled knee injection report), concluding there’s no established human safety profile yet. (PMC)
TB-500 / TB4 (humans): TB4 (not TB-500) has undergone ophthalmic trials as RGN-259 eye drops for dry eye/neurotrophic keratopathy, showing mixed but sometimes positive results and a decent safety profile as an eyedrop candidate. That does not validate injectable TB-500 for systemic healing. (PMC, ClinicalTrials.gov, Securities and Exchange Commission)

Safety, legality, and sport rules (important)

Not FDA-approved. Neither BPC-157 nor TB-500 is approved for any indication in the U.S. The FDA has explicitly flagged BPC-157 and thymosin β-4 fragments as bulk substances that “may present significant safety risks” in compounding, citing immunogenicity/impurity concerns and a lack of human safety data for proposed routes. (U.S. Food and Drug Administration)
Anti-doping: BPC-157 is prohibited for athletes under WADA’s S0 (non-approved substances); thymosin β-4 and derivatives (e.g., TB-500) are prohibited under growth factors. Current lists/USADA advisories confirm both are banned. (World Anti Doping Agency, U.S. Anti-Doping Agency (USADA))
Quality risks: Many products are sold “for research only,” with variable purity/identity; sterile-prep lapses can be dangerous. Regulators have warned broadly about infection risks from non-sterile injectables. (U.S. Food and Drug Administration)

Mechanisms people talk about (preclinical/putative)

BPC-157: anti-inflammatory and pro-healing effects in animals; interactions with nitric-oxide signaling; angiogenesis; tendon/ligament and gut mucosa repair—again, mostly animal data. (PMC)
TB-500/TB4: actin binding → enhanced cell migration; angiogenesis; tissue repair. The mechanistic work is largely from TB4 itself. (PMC)

Common claims vs. the evidence

Claim you’ll hear	What the literature supports today
“Heals tendons/ligaments fast”	Animal models are encouraging; human evidence is minimal/low-quality. (PMC)
“Great for gut repair”	Mechanistic/animal support for BPC-157; no high-quality human trials establishing efficacy. (PMC)
“Safe—almost no side effects”	FDA says insufficient human safety data; compounded versions may have immunogenicity/impurity risks. (U.S. Food and Drug Administration)
“Legal if you buy online”	Not approved drugs; athlete use is banned by WADA/USADA. (World Anti Doping Agency, U.S. Anti-Doping Agency (USADA))

Bottom line

BPC-157: intriguing preclinical peptide with many animal hits and lots of hype, but no solid, peer-reviewed human evidence for the sweeping musculoskeletal claims; not FDA-approved; flagged for safety/quality concerns; banned in sport. (PMC, U.S. Food and Drug Administration, U.S. Anti-Doping Agency (USADA))
TB-500: a fragment-based analog of TB4 with scant human data. TB4 eye-drop trials ≠ systemic TB-500 evidence. Not FDA-approved; banned in sport. (PMC, Innerbody, U.S. Anti-Doping Agency (USADA))